AQST
Aquestive Therapeutics Inc
NASDAQ: AQST · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.16
-5.07% today
Updated 2026-06-05
Market cap
$493.02M
P/E ratio
—
P/S ratio
9.81x
EPS (TTM)
$-0.61
Dividend yield
—
52W range
$3 – $8
Volume
1.5M
Aquestive Therapeutics Inc (AQST) Insider transactions
Net insider activity
Net buying (2,852,504 shares)
Buy transactions
54
Sell transactions
46
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-07 | BRAENDER, LORI J | Corporate Secretary | Sale | 135,690 | $4.23 | $573968.70 |
| 2026-05-05 | TOTH, A ERNEST JR | Chief Financial Officer | Sale | 92,652 | $4.18 | $387285.36 |
| 2026-05-05 | JUNG, CASSIE | Chief Operating Officer | Sale | 72,734 | $4.18 | $304028.12 |
| 2026-05-05 | BRAENDER, LORI J | Corporate Secretary | Sale | 76,147 | $4.18 | $318294.46 |
| 2026-05-05 | BOYD, PETER E. | Chief People Officer | Sale | 56,778 | $4.18 | $237332.04 |
| 2026-05-05 | BARBER, DANIEL | President and CEO | Sale | 335,922 | $4.18 | $1.40M |
| 2026-03-10 | TOTH, A ERNEST JR | Chief Financial Officer | Sale | 58,254 | $4.17 | $243093.94 |
| 2026-03-10 | KORCZYNSKI, SHERRY | Chief Commercial Officer | Sale | 15,741 | $4.17 | $65687.19 |
| 2026-03-10 | JUNG, CASSIE | Chief Operating Officer | Sale | 45,791 | $4.17 | $191085.84 |
| 2026-03-10 | CIOFFI, MELINA | SVP, Regulatory Affairs | Sale | 25,311 | $4.17 | $105622.80 |
| 2026-03-10 | BRAENDER, LORI J | Chief Legal Officer | Sale | 40,102 | $4.17 | $167345.65 |
| 2026-03-10 | BOYD, PETER E. | Chief People Officer | Sale | 29,814 | $4.17 | $124413.82 |
| 2026-03-10 | BARBER, DANIEL | President and CEO | Sale | 180,677 | $4.17 | $753965.12 |
| 2026-03-09 | TOTH, A ERNEST JR | Chief Financial Officer | Buy | 70,000 | — | — |
| 2026-03-09 | TOTH, A ERNEST JR | Chief Financial Officer | Buy | 95,000 | — | — |
| 2026-03-09 | KORCZYNSKI, SHERRY | Chief Commercial Officer | Buy | 42,500 | $4.29 | $182325.00 |
| 2026-03-09 | KORCZYNSKI, SHERRY | Chief Commercial Officer | Buy | 75,000 | — | — |
| 2026-03-09 | JUNG, CASSIE | Chief Operating Officer | Buy | 42,500 | — | — |
| 2026-03-09 | JUNG, CASSIE | Chief Operating Officer | Buy | 80,000 | — | — |
| 2026-03-09 | GREENHAWT, MATTHEW J. | Chief Medical Officer | Buy | 50,000 | $4.29 | $214500.00 |
| 2026-03-09 | GREENHAWT, MATTHEW J. | Chief Medical Officer | Buy | 75,000 | — | — |
| 2026-03-09 | DAVIS, MATTHEW W. | Chief Development Officer | Buy | 50,000 | — | — |
| 2026-03-09 | DAVIS, MATTHEW W. | Chief Development Officer | Buy | 50,000 | — | — |
| 2026-03-09 | CIOFFI, MELINA | SVP, Regulatory Affairs | Buy | 75,000 | $4.29 | $321750.00 |
| 2026-03-09 | CIOFFI, MELINA | SVP, Regulatory Affairs | Buy | 100,000 | — | — |
| 2026-03-09 | BRAENDER, LORI J | Chief Legal Officer | Buy | 50,000 | $4.29 | $214500.00 |
| 2026-03-09 | BRAENDER, LORI J | Chief Legal Officer | Buy | 80,000 | — | — |
| 2026-03-09 | BOYD, PETER E. | Chief People Officer | Buy | 42,500 | $4.29 | $182325.00 |
| 2026-03-09 | BOYD, PETER E. | Chief People Officer | Buy | 80,000 | — | — |
| 2026-03-09 | BARBER, DANIEL | President and CEO | Buy | 523,000 | $4.29 | $2.24M |
| 2026-03-09 | BARBER, DANIEL | President and CEO | Buy | 262,000 | — | — |
| 2025-12-04 | BOYD, PETER E. | Chief People Officer | Buy | 20,000 | — | — |
| 2025-12-02 | CIOFFI, MELINA | SVP, Regulatory Affairs | Sale | 2,083 | $5.93 | $12352.19 |
| 2025-11-10 | DAVIS, MATTHEW W. | Chief Development Officer | Buy | 50,000 | — | — |
| 2025-11-10 | DAVIS, MATTHEW W. | Chief Development Officer | Buy | 50,000 | — | — |
| 2025-10-15 | KRAUS, CARL N | Chief Medical Officer | Sale | 20,272 | $7.00 | $141904.00 |
| 2025-10-15 | JUNG, CASSIE | Chief Operating Officer | Sale | 25,000 | — | — |
| 2025-10-15 | JUNG, CASSIE | Chief Operating Officer | Sale | 67,575 | $7.01 | $473700.75 |
| 2025-10-15 | JUNG, CASSIE | Chief Operating Officer | Buy | 25,000 | $3.10 | $77567.50 |
| 2025-10-15 | BOYD, PETER E. | See Remarks | Sale | 10,000 | $7.00 | $70000.00 |
| 2025-09-26 | BOYD, PETER E. | See Remarks | Sale | 10,000 | $6.30 | $63000.00 |
| 2025-09-26 | BARBER, DANIEL | Director, President and CEO | Sale | 91,343 | $6.03 | $551191.06 |
| 2025-09-19 | BARBER, DANIEL | Director, President and CEO | Sale | 400 | $6.00 | $2400.00 |
| 2025-09-05 | BOYD, PETER E. | See Remarks | Sale | 15,000 | $5.30 | $79500.00 |
| 2025-09-04 | JUNG, CASSIE | Chief Operating Officer | Sale | 25,000 | — | — |
| 2025-09-04 | JUNG, CASSIE | Chief Operating Officer | Sale | 62,180 | $5.00 | $310900.00 |
| 2025-09-04 | JUNG, CASSIE | Chief Operating Officer | Buy | 25,000 | $3.15 | $78750.00 |
| 2025-08-14 | KORCZYNSKI, SHERRY | Chief Commercial Officer | Buy | 25,000 | — | — |
| 2025-08-09 | KRAUS, CARL N | Chief Medical Officer | Sale | 10,819 | $3.90 | $42194.10 |
| 2025-06-11 | TAGLIETTI, MARCO | Director | Buy | 42,000 | $3.41 | $143220.00 |
| 2025-06-11 | MORRIS, TIMOTHY E | Director | Buy | 42,000 | $3.41 | $143220.00 |
| 2025-06-11 | KROP, JULIE | Director | Buy | 42,000 | $3.41 | $143220.00 |
| 2025-06-11 | JENKINS, ABIGAIL L. | Director | Sale | 42,000 | $3.41 | $143220.00 |
| 2025-06-11 | COCHRAN, JOHN | Director | Buy | 42,000 | $3.41 | $143220.00 |
| 2025-06-11 | BROWN, GREGORY B | Director | Buy | 42,000 | $3.41 | $143220.00 |
| 2025-06-09 | KORCZYNSKI, SHERRY | SVP Sales and Marketing | Sale | 2,714 | $3.54 | $9607.56 |
| 2025-05-15 | CIOFFI, MELINA | SVP, Regulatory Affairs | Buy | 20,000 | — | — |
| 2025-03-10 | WARGACKI, STEPHEN | Chief Science Officer | Sale | 4,572 | $2.54 | $11612.88 |
| 2025-03-10 | JUNG, CASSIE | Chief Operating Officer | Sale | 2,182 | $2.54 | $5542.28 |
| 2025-03-09 | WARGACKI, STEPHEN | Chief Science Officer | Sale | 15,431 | $2.65 | $40892.15 |
| 2025-03-09 | TOTH, A ERNEST JR | Chief Financial Officer | Sale | 8,736 | $2.65 | $23150.40 |
| 2025-03-09 | JUNG, CASSIE | Chief Operating Officer | Sale | 7,997 | $2.65 | $21192.05 |
| 2025-03-09 | BRAENDER, LORI J | Chief Legal Officer | Sale | 10,658 | $2.65 | $28243.70 |
| 2025-03-09 | BOYD, PETER E. | See Remark | Sale | 7,681 | $2.65 | $20354.65 |
| 2025-03-09 | BARBER, DANIEL | President and CEO | Sale | 53,998 | $2.65 | $143094.70 |
| 2025-03-07 | WARGACKI, STEPHEN | Chief Science Officer | Buy | 65,000 | — | — |
| 2025-03-07 | WARGACKI, STEPHEN | Chief Science Officer | Buy | 115,000 | — | — |
| 2025-03-07 | WARGACKI, STEPHEN | Chief Science Officer | Sale | 12,859 | $2.65 | $34076.35 |
| 2025-03-07 | TOTH, A ERNEST JR | SVP, Chief Financial Officer | Buy | 82,500 | — | — |
| 2025-03-07 | TOTH, A ERNEST JR | Chief Financial Officer | Buy | 60,000 | — | — |
| 2025-03-07 | TOTH, A ERNEST JR | Chief Financial Officer | Buy | 110,000 | — | — |
| 2025-03-07 | TOTH, A ERNEST JR | Chief Financial Officer | Sale | 10,193 | $2.65 | $27011.45 |
| 2025-03-07 | KRAUS, CARL N | Chief Medical Officer | Buy | 30,000 | — | — |
| 2025-03-07 | KRAUS, CARL N | Chief Medical Officer | Buy | 70,000 | — | — |
| 2025-03-07 | KRAUS, CARL N | Chief Medical Officer | Sale | 8,115 | $2.65 | $21504.75 |
| 2025-03-07 | KORCZYNSKI, SHERRY | Chief Commercial Officer | Buy | 67,500 | — | — |
| 2025-03-07 | KORCZYNSKI, SHERRY | SVP Sales and Marketing | Buy | 35,000 | — | — |
| 2025-03-07 | KORCZYNSKI, SHERRY | SVP Sales and Marketing | Buy | 90,000 | — | — |
| 2025-03-07 | KORCZYNSKI, SHERRY | SVP Sales and Marketing | Sale | 5,428 | $2.65 | $14384.20 |
| 2025-03-07 | JUNG, CASSIE | Chief Operating Officer | Buy | 60,000 | — | — |
| 2025-03-07 | JUNG, CASSIE | Chief Operating Officer | Buy | 40,000 | — | — |
| 2025-03-07 | JUNG, CASSIE | Chief Operating Officer | Buy | 80,000 | — | — |
| 2025-03-07 | JUNG, CASSIE | Chief Operating Officer | Sale | 7,361 | $2.65 | $19506.65 |
| 2025-03-07 | BRAENDER, LORI J | Corporate Secretary | Buy | 82,500 | — | — |
| 2025-03-07 | BRAENDER, LORI J | Chief Legal Officer | Buy | 60,000 | — | — |
| 2025-03-07 | BRAENDER, LORI J | Chief Legal Officer | Buy | 110,000 | — | — |
| 2025-03-07 | BRAENDER, LORI J | Chief Legal Officer | Sale | 9,592 | $2.65 | $25418.80 |
| 2025-03-07 | BOYD, PETER E. | Chief People Officer | Buy | 60,000 | — | — |
| 2025-03-07 | BOYD, PETER E. | See Remark | Buy | 40,000 | — | — |
| 2025-03-07 | BOYD, PETER E. | See Remark | Buy | 80,000 | — | — |
| 2025-03-07 | BOYD, PETER E. | See Remark | Sale | 6,624 | $2.65 | $17553.60 |
| 2025-03-07 | BARBER, DANIEL | President and CEO | Buy | 293,100 | — | — |
| 2025-03-07 | BARBER, DANIEL | President and CEO | Buy | 408,000 | — | — |
| 2025-03-07 | BARBER, DANIEL | President and CEO | Buy | 272,000 | — | — |
| 2025-03-07 | BARBER, DANIEL | President and CEO | Sale | 29,307 | $2.65 | $77663.55 |
| 2024-12-02 | BRATTON, DOUGLAS K | 10% Owner | Sale | 40,000 | — | — |
| 2024-11-26 | JUNG, CASSIE | Chief Operating Officer | Sale | 44 | $4.87 | $214.06 |
| 2024-08-09 | KRAUS, CARL N | Chief Medical Officer | Sale | 10,819 | $3.43 | $37109.17 |
| 2024-06-20 | TAGLIETTI, MARCO | Director | Buy | 38,000 | — | — |
| 2024-06-20 | MORRIS, TIMOTHY E | Director | Buy | 38,000 | — | — |
Frequently asked questions
Are AQST insiders buying or selling?
Over the transactions on record, AQST insiders have been net buyers, with about $7.34M in stock sold across 46 sales, against 13 open-market purchases.
Does insider selling at AQST mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which AQST insiders are selling the most?
Recent selling is concentrated in a few names. BARBER, DANIEL accounts for the largest share on record, with about $2.93M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.